Clinical Trials Browser

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT06097962 2026-03-20

Safety and Efficacy of NK510 to Treat NSCLC

Phase EARLY_PHASE1 Recruiting

12 enrolled

Thoracic

Pleural Effusion, Malignant

NCT07192900 2026-01-15

(RIOT 4A)

Phase 1 Recruiting

10 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT05620329 2025-10-16

UNC Pleural Fluid Registry

Recruiting

9,999 enrolled

BreastThoracic

Breast Neoplasms, Empyema, Infections, Lung Neoplasms, Neoplasms, Pleural Effusion, Malignant

NCT07147270 2025-08-29

Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound

Phase NA Recruiting

30 enrolled

Thoracic

Pleural Effusion, Malignant

NCT07120867 2025-08-13

Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial

Phase NA Recruiting

95 enrolled

MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

NCT05543330 2025-07-20

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

Phase 1/2 Recruiting

96 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT06016179 2025-05-22

RIOT2

Phase 1 Recruiting

12 enrolled

Thoracic

Pleural Effusion, Malignant

NCT06959719 2025-05-07

ARMSTRONG

Phase NA Recruiting

41 enrolled

MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Pleural Effusion, Malignant

NCT06946498 2025-04-27

FLAT

Phase NA Recruiting

100 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Pleural Effusion, Pleural Effusion, Malignant

Clinical Trials

RIOT 4B

Safety and Efficacy of NK510 to Treat NSCLC

(RIOT 4A)

UNC Pleural Fluid Registry

Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound

Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

RIOT2

ARMSTRONG

FLAT